In addition, in combination with immunoprecipitation experiments, it was verified that the formation of a transcriptional activation complex between AIB1 and PCAF activates the glycolytic process to a greater extent than AIB1 alone to affect tumor progression. The gene discussed is NCOA3; the disease is neoplasm.